A detailed history of Truist Financial Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Truist Financial Corp holds 3,885,251 shares of TEVA stock, worth $69.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,885,251
Previous 3,630,768 7.01%
Holding current value
$69.4 Million
Previous $51.2 Million 23.24%
% of portfolio
0.1%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 20, 2024

BUY
$12.78 - $17.4 $3.25 Million - $4.43 Million
254,483 Added 7.01%
3,885,251 $63.1 Million
Q1 2024

May 10, 2024

BUY
$10.67 - $14.43 $37.3 Million - $50.5 Million
3,496,746 Added 2609.08%
3,630,768 $51.2 Million
Q4 2023

Feb 02, 2024

BUY
$8.12 - $10.63 $14,339 - $18,772
1,766 Added 1.34%
134,022 $1.4 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $313,374 - $448,276
-41,895 Reduced 24.06%
132,256 $1.35 Million
Q2 2023

Aug 01, 2023

BUY
$7.2 - $9.47 $264,326 - $347,662
36,712 Added 26.71%
174,151 $1.31 Million
Q1 2023

May 05, 2023

SELL
$8.36 - $11.37 $114,506 - $155,734
-13,697 Reduced 9.06%
137,439 $1.22 Million
Q4 2022

Feb 17, 2023

SELL
$7.95 - $9.48 $65,388 - $77,973
-8,225 Reduced 5.16%
151,136 $1.38 Million
Q3 2022

Oct 26, 2022

BUY
$6.86 - $11.95 $174,737 - $304,390
25,472 Added 19.02%
159,361 $1.29 Million
Q2 2022

Jul 22, 2022

SELL
$7.38 - $10.4 $222,521 - $313,580
-30,152 Reduced 18.38%
133,889 $1.01 Million
Q1 2022

Apr 22, 2022

SELL
$7.33 - $9.39 $49,997 - $64,049
-6,821 Reduced 3.99%
164,041 $1.54 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $276,539 - $356,700
35,005 Added 25.77%
170,862 $1.37 Million
Q3 2021

Nov 05, 2021

BUY
$8.38 - $10.18 $197,483 - $239,901
23,566 Added 20.99%
135,857 $1.32 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $22,007 - $25,697
-2,223 Reduced 1.94%
112,291 $1.11 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $752,421 - $932,158
72,768 Added 174.31%
114,514 $1.32 Million
Q4 2020

Feb 18, 2021

SELL
$8.61 - $11.04 $591,205 - $758,061
-68,665 Reduced 62.19%
41,746 $402,000
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $9,598 - $14,212
1,120 Added 1.02%
110,411 $995,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $117,066 - $189,151
-14,417 Reduced 11.65%
109,291 $1.35 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $32,867 - $66,079
-4,913 Reduced 3.82%
123,708 $1.11 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $839,895 - $1.38 Million
128,621 New
128,621 $1.26 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.